Predicting for anti-(mutant) SARS-CoV-2 and anti-inflammation compounds of Lianhua Qingwen Capsules in treating COVID-19.

Liang HongMin HeShao-Ping LiJing Zhao

Published in: Chinese medicine (2022)

In summary, this study explored the potential anti-(mutant) SARS-CoV-2 and anti-inflammation compounds of LHQW against COVID-19, which can provide new ideas and valuable references for discovering active compounds in the treatment of COVID-19.

Keyphrases

sars cov
coronavirus disease
respiratory syndrome coronavirus
oxidative stress
risk assessment